Title:
マグネシウム含有オキシトシン製剤および使用の方法
Document Type and Number:
Japanese Patent JP7093559
Kind Code:
B2
Abstract:
Disclosed are methods and compositions for the treatment of autism spectrum disorder, related disorders and symptoms of such disorders, comprising co-administration of an oxytocin peptide and magnesium ions. Co-administration of an oxytocin peptide and magnesium ions results in a synergistic or enhanced effect on reducing social and communication deficits in a patient suffering from an autism spectrum disorder.
More Like This:
Inventors:
Carson, dean
Yomans, David Sea.
Yomans, David Sea.
Application Number:
JP2018553235A
Publication Date:
June 30, 2022
Filing Date:
April 12, 2017
Export Citation:
Assignee:
Trigemina, Incorporated
International Classes:
A61K38/095; A61K9/08; A61K9/12; A61K47/02; A61M11/00; A61M15/08; A61P25/22
Foreign References:
| WO2004030524A1 |
Other References:
Endocrinology, 1997, Vol. 138, pp.2829-2834
European peptide Symposium, 2001, pp.925-926
Journal of Pharmacology and Experimental Therapeutics, 1974, Vol.190, pp.77-87
European peptide Symposium, 2001, pp.925-926
Journal of Pharmacology and Experimental Therapeutics, 1974, Vol.190, pp.77-87
Attorney, Agent or Firm:
Shusaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Previous Patent: Flying pest attractant
Next Patent: Watertight structure for flap gate and flap gate equipped with this
Next Patent: Watertight structure for flap gate and flap gate equipped with this